Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Aminolevulinic Acid × 30 days × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 3 Glioblastoma 3 Skin Diseases 2 Precancerous Conditions 2 Sarcoma 1 Oligodendroglioma 1 Astrocytoma 1

Interventions

Specimen Handling 6 Cyclophosphamide 5 Biopsy 5 Temozolomide 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 pazopanib 3 X-Rays 3 Vincristine 3 Trabectedin 3 Irinotecan 3 Ifosfamide 3 Doxorubicin 3 regorafenib 2 pembrolizumab 2 fludarabine 2 atezolizumab 2 Sirolimus 2 Radiation 2 Phantoms, Imaging 2 Metastasectomy 2 Gemcitabine 2 Etoposide 2 trastuzumab deruxtecan 1 tivozanib 1 temsirolimus 1 tazemetostat 1 talimogene laherparepvec 1 selinexor 1 polyethylene glycol 8000 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07038278 2026-02-27

5-ALARMS

University of Colorado, Denver

Phase EARLY_PHASE1 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡